Abstract:Objective\r\nIt is well known that the suppression of gastric acidity is one of the most essential factors in promoting healing and preventing relapse of peptic ulcers. Little is known, however, about how to inhibit gastric acid secretion effectively in children with peptic ulcers. The present study aimed at understanding the optimal acid suppression by examining the relationship between ulcer healing and the suppression of gastric acid in children.\r\n\r\n\r\nMethods\r\nPatients with peptic ulcers diagnosed by endoscopy were randomized to receive either oral ranitidine (group A) or oral omeprazole (group B) for 4-6 weeks (mean 5 weeks) . Intragastric 24-hour pH monitoring was performed before treatment, and repeated three times: on day 1, weeks 1 and 5 post-dosing. Endoscopy was repeated on week 5 to evaluate the healing condition of ulcers.\r\n\r\n\r\nResults\r\nTwenty-seven patients followed up by endoscopy and pH monitoring were eligible for final analysis. The ulcers in 16 patients of group A and in all (11 cases) of group B were healed. No significant differences in the gastric mean pH, median pH and percentage of time with gastric pH \u003e 3 between the two groups were observed before treatment. Gastric pH increased significantly after treatment in both groups. These parameters in group A decreased significantly during weeks 1 and 5 as compared to those on day 1 post-dosing; the duration of drug action was also shortened significantly. The gastric mean pH and mean median pH in group B were significantly higher during weeks 1 and 5than on day 1 of post-dosing, the duration of drug action was also prolonged significantly. According to the result of endoscopic re-examination, the authors subdivided group A into unhealed (group C) and healed (group D) groups. The gastric acid suppressive effect in group C attenuated significantly by the end of the 5-week treatment and the differences of gastric mean pH and median pH, percentage of time with pH \u003e 3 between week 5 and pre-treatment level were not significant. While these parameters in group D were still significantly higher during week 5than those obtained before treatment. The gastric mean pH and median pH, percentage of time with pH \u003e 3 and the duration of drug action during week 5 were significantly higher in group D than in group C. The mean shortest duration of drug action in group B was 10 h, while it was 5 h in group D.\r\n\r\n\r\nConclusions\r\nThe onset of tolerance to ranitidine during the therapy might have affected healing of ulcers in the subjects. The optimal acid suppression for healing ulcere in children could be regarded as maintaining the gastric pH \u003e 3 for 5-10 hours a day of post-dosing during 4-6 weeks of anti-secretory treatment.\r\n\r\n\r\nKey words: \r\nPeptic ulcer; Hydrogen-ion concentration; Ranitidine; Omeprazole; Drug tolerance

Use of H2-receptor antagonists in children.

Optimal suppression of gastric acid and ulcer healing in children with peptic ulcer

The Use of H 2 ‐Receptor Antagonist in the Treatment of Peptic Ulcer Disease in Children

Pediatric Gastroesophageal Reflux Disease and Acid-Related Conditions: Trends in Incidence of Diagnosis and Acid Suppression Therapy.

Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998–2019): A population‐based assessment

Acid-Suppression Medications and the Risk of Hospital-Acquired Acute Kidney Injury in Children

Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists-In Vitro Studies and a Systematic Literature Review

Healthcare Costs of GERD and Acid-Related Conditions in Pediatric Patients, with Comparison Between Histamine-2 Receptor Antagonists and Proton Pump Inhibitors

Acid Suppression Use among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study

Inhibiting the proton pump: mechanisms, benefits, harms, and questions

Potassium-competitive acid blockers: rethinking acid suppression for gastroesophageal reflux disease and Helicobacter pylori

Proton Pump Inhibitors in Children: the Good, the Bad, and the Ugly

The Evolving Role of the Laboratory Professional in the Age of Genome Sequencing: A Vision of the Association for Molecular Pathology.

Proton Pump Inhibitors in Pediatrics: Relevant Pharmacokinetics and Pharmacodynamics

Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments

Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study

Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data

Helicobacter pylori in Children and Adolescents: Increase of Primary Clarithromycin Resistance, 1997–2000

Magnetic Reconnection and Mass Acceleration in Flare-Coronal Mass Ejection Events

New insight into the control of peptic ulcer by targeting the histamine H2 receptor

Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker